{"data":[{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"LAMPERT MARK N","reportingCik":"0001233840","personType":"IN","sharesOwned":8939731,"percentOfClass":9.8,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"BVF INC/IL","reportingCik":"0001056807","personType":"CO","sharesOwned":8939731,"percentOfClass":9.8,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":"0001055947","personType":"IA,PN","sharesOwned":8939731,"percentOfClass":9.8,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":"0001803809","personType":"OO","sharesOwned":8303781,"percentOfClass":9.1,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":"0000918923","personType":"PN","sharesOwned":5946981,"percentOfClass":6.6,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"BVF I GP LLC","reportingCik":"0001803805","personType":"OO","sharesOwned":5946981,"percentOfClass":6.6,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":"0001102444","personType":"PN","sharesOwned":2356800,"percentOfClass":2.7,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"BVF II GP LLC","reportingCik":"0001803806","personType":"OO","sharesOwned":2356800,"percentOfClass":2.7,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":"0001660683","personType":"PN","sharesOwned":347970,"percentOfClass":0.4,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"BVF Partners OS Ltd.","reportingCik":"0001660684","personType":"CO","sharesOwned":347970,"percentOfClass":0.4,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000921895-26-002806","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-14","reportingPerson":"Hrustanovic Gorjan","reportingCik":"0001821194","personType":"IN","sharesOwned":183645,"percentOfClass":0.2,"filedAt":"2026-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000315066-26-002088","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS INC","ticker":"OLMA","cusip":"68062P106","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":12075061.72,"percentOfClass":13.8,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000315066-26-002088","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS INC","ticker":"OLMA","cusip":"68062P106","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":12075061.72,"percentOfClass":13.8,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0002012383-26-002839","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":6244212,"percentOfClass":7.1,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0001274173-26-000150","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS, INC.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":7108488,"percentOfClass":8.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0001193125-26-226930","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS, INC.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Bain Capital Life Sciences Opportunities IV, L.P.","reportingCik":null,"personType":"PN","sharesOwned":7473238,"percentOfClass":8.15,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0002005369-26-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-16","reportingPerson":"Raymond Debbane","reportingCik":null,"personType":"IN","sharesOwned":4461949,"percentOfClass":5.1,"filedAt":"2026-03-20","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0002005369-26-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-16","reportingPerson":"Invus Public Equities, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3898500,"percentOfClass":4.5,"filedAt":"2026-03-20","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0002005369-26-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-16","reportingPerson":"Invus Public Equities Advisors, LLC","reportingCik":null,"personType":"OO","sharesOwned":3898500,"percentOfClass":4.5,"filedAt":"2026-03-20","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0002005369-26-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-16","reportingPerson":"Invus Global Management, LLC","reportingCik":null,"personType":"OO","sharesOwned":3898500,"percentOfClass":4.5,"filedAt":"2026-03-20","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0002005369-26-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-16","reportingPerson":"Siren, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":3898500,"percentOfClass":4.5,"filedAt":"2026-03-20","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0002005369-26-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-16","reportingPerson":"Avicenna Life Sci Master GP LLC","reportingCik":null,"personType":"OO","sharesOwned":563449,"percentOfClass":0.6,"filedAt":"2026-03-20","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0002005369-26-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-16","reportingPerson":"Ulys, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":563449,"percentOfClass":0.6,"filedAt":"2026-03-20","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0002005369-26-000019","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":"68062P106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-16","reportingPerson":"Avicenna Life Sci Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":563449,"percentOfClass":0.6,"filedAt":"2026-03-20","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000315066-26-000648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS INC","ticker":"OLMA","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":9998059.72,"percentOfClass":12.5,"filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000315066-26-000648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS INC","ticker":"OLMA","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":9998059.72,"percentOfClass":12.5,"filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0001193125-26-054823","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS, INC.","ticker":"OLMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Bain Capital Life Sciences Opportunities IV, L.P.","reportingCik":null,"personType":"PN","sharesOwned":8508641,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0001274173-26-000089","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS, INC.","ticker":"OLMA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":6710194,"percentOfClass":8.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0001172661-26-000718","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0001172661-26-000718","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0001172661-26-000718","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001750284","issuerName":"Olema Pharmaceuticals, Inc.","ticker":"OLMA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000315066-26-000501","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS INC","ticker":"OLMA","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":5023092.35,"percentOfClass":6.3,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0000315066-26-000501","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS INC","ticker":"OLMA","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":5023092.35,"percentOfClass":6.3,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/olma"},{"accessionNo":"0001274173-25-000273","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001750284","issuerName":"OLEMA PHARMACEUTICALS, INC.","ticker":"OLMA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":3585849,"percentOfClass":5.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/olma"}],"updatedAt":"2026-11-03T17:41:07.040Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/olma","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}